Medical devices refer to instruments, machines or appliances essential to the delivery of healthcare and designed for diagnosis, monitoring, cure or prevention of any disease or for some other specific medical purposes. The medical devices market can be classified into the following segments: general medical, orthopedic, cardiovascular, respiratory, home healthcare, surgical devices, etc.
North America has the competitive advantage on the market, accounting for the market share of above 45%. Technological advancements in medicine, introduction of new treatment modes, product innovations, expansion of the medical facilities infrastructure, rising health awareness, growing population and the increasing number of elderly people are the key drivers of the global medical devices market. Abbott Labs, Johnson & Johnson, Baxter, Medtronic, Becton Dickinson, Boston Scientific, Stryker Corporation, GE Healthcare Technologies and Beckman Coulter are amid the most recognized participants of the industry.
The catalogue encompasses a wealthy collection of research reports providing extensive analyses of the medical devices market at all geographical levels possible. The researches present the essential findings on the market dynamics, identify the main market barriers and opportunities. The reports also evaluate the market competition and point out top market players. Besides, the future forecasts for the market are revealed in the research reports.
Publications found:
681
Sort by:
Brain-Computer Interface (BCI) for Rehabilitation Market Forecasts to 2034 – Global Analysis By BCI Type (Invasive BCI, Partially Invasive BCI, Non-Invasive BCI, Hybrid BCI and Other BCI Types), Technology, Rehabilitation Type, Device Type, End User, and Geography
US$ 4,150.00
According to Stratistics MRC, the Global Brain-Computer Interface (BCI) for Rehabilitation Market is accounted for $2.4 billion in 2026 and is expected to reach $14.2 billion by 2034 growing at a CAGR...
August 2026
200 pages
Smart Insulin Delivery Devices Market Forecasts To 2034 – Global Analysis By Device Type (Smart Insulin Pens, Smart Insulin Pumps, Smart Insulin Patch Pumps, Automated Insulin Delivery Systems and Connected Insulin Delivery Devices), Technology, Delivery Mechanism, Component, Connectivity Type, Patient Type, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Smart Insulin Delivery Devices Market is accounted for $1.1 billion in 2026 and is expected to reach $2.7 billion by 2034 growing at a CAGR of 11.8% during the...
August 2026
200 pages
